CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer.
Pharoah PD, Oliveira C, Machado JC, Keller G, Vogelsang H, Laux H, Becker KF, Hahn H, Paproski SM, Brown LA, Caldas C, Huntsman D.
Pharoah PD, et al.
Int J Cancer. 2002 Sep 10;101(2):196-7. doi: 10.1002/ijc.10590.
Int J Cancer. 2002.
PMID: 12209998